Fundraising & Investor Relations
Connecting Scientific Innovation with Capital and Strategic Growth.
Fundraising & Investor Relations connects scientific innovation with the capital, partnerships, and strategic decisions required to advance development and commercial growth.
For biotech, pharmaceutical, and medical technology companies, attracting investment requires more than promising science. Investors need to understand the clinical opportunity, regulatory pathway, competitive landscape, commercial potential, and milestones that will determine future value.
At Amodaia, we work with founders, executive teams, and investors to develop compelling investment propositions grounded in scientific evidence and commercial reality. Combining life-sciences expertise, strategic insight, and an understanding of investor expectations, we help organisations articulate their value, strengthen investment readiness, and communicate with confidence.
From early fundraising preparation and investment positioning to investor engagement, due diligence support, and strategic partnership development, we provide senior-level advisory and specialist execution tailored to each organisation's growth objectives.
Our Services Include:
- Fundraising strategy, investment readiness, and capital requirements planning
- Investment thesis development, equity storytelling, and strategic positioning
- Investor pitch decks, executive summaries, and investment communications
- Investor landscape research, segmentation, and engagement strategy
- Scientific, clinical, regulatory, and commercial due diligence preparation
- Competitive intelligence, market opportunity assessment, and development milestone mapping
- Strategic partnership identification, positioning, and business development support
- Investor relations communications, stakeholder engagement, and ongoing investment narrative development
Our Fundraising & Investor Relations approach combines scientific expertise, commercial understanding, and strategic judgement to help organisations present credible investment opportunities and engage stakeholders effectively.
Where appropriate, our Narrative Integrity Framework™ provides an additional layer of scrutiny, examining whether scientific evidence, regulatory assumptions, commercial forecasts, and investment claims support a coherent and defensible proposition.
Case Studies
Biotech
| United States – Fundraising & Investor Relations Narrative and Outreach
Challenge: A pre-Series A biotechnology company needed to translate its scientific programme into a credible investment proposition, clarify its competitive positioning, and prepare for engagement with potential investors.
Solution: Amodaia supported the development of the investment thesis, reviewed the scientific and commercial proposition, refined investor communications, and helped structure an investor engagement approach aligned with the company's development milestones.
Impact: A clearer investment proposition, more consistent investor materials, and a structured approach to investor engagement and due diligence preparation.
Challenge: A pre-Series A biotechnology company needed to translate its scientific programme into a credible investment proposition, clarify its competitive positioning, and prepare for engagement with potential investors.
Solution: Amodaia supported the development of the investment thesis, reviewed the scientific and commercial proposition, refined investor communications, and helped structure an investor engagement approach aligned with the company's development milestones.
Impact: A clearer investment proposition, more consistent investor materials, and a structured approach to investor engagement and due diligence preparation.
